Real-time enrollment status for this solid tumors clinical trial
Current Status
Completed
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05795595 |
| Recruiting Status | Completed |
| Condition | Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 250 participants |
| Active Locations | 7 sites in the US |
| Sponsor | CRISPR Therapeutics AG |
| Last Updated on CT.gov | November 26, 2025 (Nov 26, 2025) |
As of March 2, 2026: Clinical trial NCT05795595 is currently completed participants. This clinical trial study for solid tumors is not currently accepting new participants at 7 locations across the United States. The study is sponsored by CRISPR Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05795595 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05795595 was last updated Nov 26, 2025 (November 26, 2025). HelloStudys verifies this status automatically.